This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Narisawa-Saito, M. Articles by Kiyono, T. PubMed PubMed Citation Articles by Narisawa-Saito, M. Articles by Kiyono, T.

An In vitro Multistep Carcinogenesis Model for Human Cervical Cancer

¹ Virology Division and ² Pathology Division, National Cancer Center Research Institute, Chuo-ku, Japan; and ³ Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

Requests for reprints: Tohru Kiyono, Virology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuohku, Tokyo 104-0045, Japan. Phone: 81-3-3542-2511; Fax: 011-81-3-3543-2181; E-mail: tkiyono{at}ncc.go.jp.

Key Words: human papillomavirus type 16 • E6E7 • Hras • c-myc • primary human cervical keratinocytes • cervical cancer

Human papillomaviruses (HPV) are believed to be the primary causal agents for development of cervical cancer, and deregulated expression of two viral oncogenes E6 and E7 in basal cells, mostly by integration, is considered to be a critical event for disease progression. However, lines of evidence suggest that, besides expression of E6 and E7 genes, additional host genetic alterations are required for cancer development. To directly test this hypothesis, we first transduced HPV16 E6 and E7 with or without hTERT into several lines of normal human cervical keratinocytes (HCK) from independent donors and then searched for additional alterations required for carcinogenesis. Oncogenic Hras^G12V (Hras) provided marked tumor forming ability in nude mice and ErbB2 or c-Myc (Myc) endowed weaker but significant tumor forming ability. Combined transduction of Myc and Hras to HCKs expressing E6 and E7 resulted in the creation of highly potent tumor-initiating cells. These results show that only one or two genetic changes occurring after deregulated expression of high-risk HPV oncogenes might be sufficient for development of cervical cancer. [Cancer Res 2008;68(14):5699–705]